- Targeting the androgen receptor for knockout using siRNA/RNA interference strategies
- Inhibiting androgen signaling using small molecules that bind to the androgen receptor
- Determining mechanisms of ERG-mediated prostatic carcinogenesis
- Identification of changes in the genomes and transcriptomes of tumors mechanistically linked to the emergence of metastasis and drug resistance
- Developing novel tumour targeting technologies based on malarial protein VAR2
- Determining the role of Semaphorin 3C in treatment resistance of prostate cancer
- Targeting BRN2 in neuroendocrine prostate cancer
- Developing biomarker assays using circulating tumour DNA (ctDNA)
- Evaluating new probes for PET imaging of prostate cancer
Updated January 30, 2020
